Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data

Lung adenocarcinoma (LUAD) is the most common subtype of non-small cell lung cancer associated with an unstable prognosis. Thus, there is an urgent demand for the identification of novel diagnostic and prognostic biomarkers as well as targeted drugs for LUAD. The present study aimed to identify pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chengrui, Wan, Yufeng, Deng, Weijun, Fei, Fan, Wang, Linlin, Qi, Fuwei, Zheng, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692660/
https://www.ncbi.nlm.nih.gov/pubmed/35028418
http://dx.doi.org/10.1515/med-2021-0375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692660/
https://www.ncbi.nlm.nih.gov/pubmed/35028418
http://dx.doi.org/10.1515/med-2021-0375

Ejemplares similares